The SureSeq™ CLL + CNV Panel has been designed to detect 12 key genes and 5 chromosomal regions implicated in chronic lymphocytic leukemia (CLL) progression. The panel can detect both small and large copy number variations at 10% minor allele frequency, single-nucleotide variants and indels down to 1% minor allele frequency, and loss of heterozygosity at 5–10 Mb. As explained by the company, the panel can streamline users’ CLL research to deliver a comprehensive genomic profile for each CLL sample using a single workflow.
